| Where: Innovation AveNEW 2 |
|
Salve Therapeutics is developing a bioengineering software platform called VirCAD© (Virus Computer-Aided Design) that will:
1. Cost-effectively mine the human virome (and others) for new therapeutic modalities that will enable exploration of this therapeutic space.
2. Discover novel drug candidates via the design, modeling and simulation of novel viral particles in silico.
3. Manufacture better viral delivery methods that would expand the available viral biologic tool kit to produce better precision medicines.
4. Help treat and potentially cure the many inherited and acquired genetic disorders afflicting humanity due to the therapeutic specificity, efficiency and customizability of viral biologics.
